Burroughs Amy L.
SEC CIK 1872564 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Dir | 73.3K | $141.6K | — | 3 | 2021-08-16 | 2023-01-03 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
Burroughs Amy L. made no open-market trades at DMAC in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | 2023-01-03 | DMAC | DiaMedica Therapeutics Inc. | Burroughs Amy L. | Dir | A - Grant | $1.53 | +17.2K | 73.3K | +31% | +$26.2K | |
| 2022-01-03 | 2022-01-03 | DMAC | DiaMedica Therapeutics Inc. | Burroughs Amy L. | Dir | A - Grant | $3.58 | +11.2K | 56.1K | +25% | +$40.0K | |
| 2021-08-17 | 2021-08-16 | DMAC | DiaMedica Therapeutics Inc. | Burroughs Amy L. | Dir | P - Purchase | $3.15 | +45.0K | 45.0K | New | +$141.6K |
Purchase Sale Sale after option exercise All abbreviations